Увійти

Готові списки джерел за темами / Neuromuscular transmission / Статті в журналах

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Neuromuscular transmission.

Статті в журналах з теми "Neuromuscular transmission"

Автор: Grafiati

Опубліковано: 4 червня 2021

Оновлено: 31 липня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Neuromuscular transmission".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

MacLean, Ian C. "Neuromuscular Transmission." Physical Medicine and Rehabilitation Clinics of North America 1, no. 1 (November 1990): 43–52. http://dx.doi.org/10.1016/s1047-9651(18)30745-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Parker, C. "Neuromuscular transmission." Postgraduate Medical Journal 74, no. 870 (April 1, 1998): 255. http://dx.doi.org/10.1136/pgmj.74.870.255-a.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Torda, T. A. "Monitoring Neuromuscular Transmission." Anaesthesia and Intensive Care 30, no. 2 (April 2002): 123–33. http://dx.doi.org/10.1177/0310057x0203000202.

Повний текст джерела

Анотація:

Persistent neuromuscular blockade is not uncommon in the recovery room and contributes to postoperative morbidity and possibly mortality. The use of neuromuscular monitoring and intermediate rather than long-acting neuromuscular blocking drugs have been shown to reduce its incidence. Clinically available methods of detecting and quantitating neuromuscular blockade are reviewed. The writer concludes that such monitoring should be routine when neuromuscular blocking drugs are used.

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Beemer, G. H., and P. H. Goonetilleke. "Monitoring neuromuscular transmission." Current Anaesthesia & Critical Care 7, no. 2 (April 1996): 101–6. http://dx.doi.org/10.1016/s0953-7112(96)80065-2.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Pascuzzi, Robert. "Disorders of Neuromuscular Transmission." Seminars in Neurology 24, no. 02 (July 15, 2004): 137. http://dx.doi.org/10.1055/s-2004-830898.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Weissman, J. D. "Electromyography: Neuromuscular Transmission Studies." Neurology 39, no. 8 (August 1, 1989): 1141. http://dx.doi.org/10.1212/wnl.39.8.1141-b.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Meistelman, Claude. "Monitoring of neuromuscular transmission." Current Opinion in Anaesthesiology 6, no. 4 (August 1993): 720–25. http://dx.doi.org/10.1097/00001503-199308000-00024.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Wareham, Anthony C. "Neuromuscular function and transmission." Anaesthesia & Intensive Care Medicine 6, no. 6 (June 2005): 203–5. http://dx.doi.org/10.1383/anes.6.6.203.65787.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Krendel, David. "Hypermagnesemia and Neuromuscular Transmission." Seminars in Neurology 10, no. 01 (March 1990): 42–45. http://dx.doi.org/10.1055/s-2008-1041252.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

WINDSOR, J. P. W., P. S. SEBEL, and P. J. FLYNN. "The neuromuscular transmission monitor." Anaesthesia 40, no. 2 (February 22, 2007): 146–51. http://dx.doi.org/10.1111/j.1365-2044.1985.tb10705.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Henning, R. H. "Purinoceptors in neuromuscular transmission." Pharmacology & Therapeutics 74, no. 1 (January 1997): 115–28. http://dx.doi.org/10.1016/s0163-7258(97)00015-6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Fletcher, Allan. "Neuromuscular function and transmission." Anaesthesia & Intensive Care Medicine 9, no. 6 (June 2008): 256–58. http://dx.doi.org/10.1016/j.mpaic.2008.04.005.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Fletcher, Allan. "Neuromuscular function and transmission." Anaesthesia & Intensive Care Medicine 12, no. 6 (June 2011): 245–48. http://dx.doi.org/10.1016/j.mpaic.2011.03.012.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

MAELICKE, ALFRED, T. COBAN, A. SCHRATTENHOLZ, B. SCHRÖDER, S. REINHARDT-MAELICKE, A. STORCH, J. GODOVAC-ZIMMERMANN, CHRISTOPH METHFESSEL, E. F. R. PEREIRA, and EDSON X. ALBUQUERQUE. "Physostigmine and Neuromuscular Transmission." Annals of the New York Academy of Sciences 681, no. 1 Myasthenia Gr (June 1993): 140–54. http://dx.doi.org/10.1111/j.1749-6632.1993.tb22880.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Martin, A. Robert. "Principles of Neuromuscular Transmission." Hospital Practice 27, no. 8 (August 15, 1992): 147–58. http://dx.doi.org/10.1080/21548331.1992.11705473.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Torda, T. A. "Book Review: Neuromuscular Transmission." Anaesthesia and Intensive Care 29, no. 4 (August 2001): 439. http://dx.doi.org/10.1177/0310057x0102900420.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Hirst, G. D. S., S. De Gleria, and D. F. van Helden. "Neuromuscular transmission in arterioles." Experientia 41, no. 7 (July 1985): 874–79. http://dx.doi.org/10.1007/bf01970004.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Sherman, Howard B. "Electromyography: Neuromuscular transmission studies." Surgical Neurology 31, no. 2 (February 1989): 163. http://dx.doi.org/10.1016/0090-3019(89)90336-4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Schelhaas, H. Jurgen, Bart P. C. Van De Warrenburg, Hubertus P. H. Kremer, and Machiel J. Zwarts. "Neuromuscular transmission in SCA6." Annals of Neurology 55, no. 3 (2004): 451–52. http://dx.doi.org/10.1002/ana.20015.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Pascuzzi, Robert. "Introduction to the Neuromuscular Junction and Neuromuscular Transmission." Seminars in Neurology 10, no. 01 (March 1990): 1–5. http://dx.doi.org/10.1055/s-2008-1041246.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

UEDA, NAOYUKI. "Clinical Assessment of Neuromuscular Transmission." JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 15, no. 3 (1995): 197–201. http://dx.doi.org/10.2199/jjsca.15.197.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Vincent, Angela. "Autoantibodies in neuromuscular transmission disorders." Annals of Indian Academy of Neurology 11, no. 3 (2008): 140. http://dx.doi.org/10.4103/0972-2327.42932.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Fagerlund, M. J., and L. I. Eriksson. "Current concepts in neuromuscular transmission." British Journal of Anaesthesia 103, no. 1 (July 2009): 108–14. http://dx.doi.org/10.1093/bja/aep150.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Marshall, Ian G. "Prejunctional aspects of neuromuscular transmission." Current Opinion in Anaesthesiology 4, no. 4 (August 1991): 577–82. http://dx.doi.org/10.1097/00001503-199108000-00021.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Martyn, J. A. J., M. Jonsson Fagerlund, and L. I. Eriksson. "Basic principles of neuromuscular transmission." Anaesthesia 64 (March 2009): 1–9. http://dx.doi.org/10.1111/j.1365-2044.2008.05865.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Engel, Andrew. "Congenital Disorders of Neuromuscular Transmission." Seminars in Neurology 10, no. 01 (March 1990): 12–26. http://dx.doi.org/10.1055/s-2008-1041248.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Lange, D. J. "Electrophysiologic testing of neuromuscular transmission." Neurology 48, Supplement 5 (April 1, 1997): 18S—22S. http://dx.doi.org/10.1212/wnl.48.suppl_5.18s.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Sieb, J. P. "Fluoroquinolone antibiotics block neuromuscular transmission." Neurology 50, no. 3 (March 1, 1998): 804–7. http://dx.doi.org/10.1212/wnl.50.3.804.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

JONES, R. M. "Neuromuscular transmission and its blockade." Anaesthesia 40, no. 10 (October 1985): 964–76. http://dx.doi.org/10.1111/j.1365-2044.1985.tb10551.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Schulze, J., M. Toepfer, K.-C. Schroff, S. Aschhoff, J. Remien, W. Müller-Felber, and S. Endres. "Clindamycin and nicotinic neuromuscular transmission." Lancet 354, no. 9192 (November 1999): 1792–93. http://dx.doi.org/10.1016/s0140-6736(99)02881-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Enomoto, Koh-Ichi, and Charles Edwards. "Thiamine blockade of neuromuscular transmission." Brain Research 358, no. 1-2 (December 1985): 316–23. http://dx.doi.org/10.1016/0006-8993(85)90976-x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Kaminski, Henry J., and Robert L. Ruff. "Congenital Disorders of Neuromuscular Transmission." Hospital Practice 27, no. 9 (September 15, 1992): 73–85. http://dx.doi.org/10.1080/21548331.1992.11705484.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Mahadeva, Branavan, Lawrence Phillips, and Vern Juel. "Autoimmune Disorders of Neuromuscular Transmission." Seminars in Neurology 28, no. 2 (April 2008): 212–27. http://dx.doi.org/10.1055/s-2008-1062260.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Saldien, V., and K. M. Vermeyen. "Neuromuscular transmission monitoring in children." Pediatric Anesthesia 14, no. 4 (April 2004): 289–92. http://dx.doi.org/10.1046/j.1460-9592.2003.01152.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Sieb, Jo¨rn P., and Andrew G. Engel. "Ephedrine: effects on neuromuscular transmission." Brain Research 623, no. 1 (September 1993): 167–71. http://dx.doi.org/10.1016/0006-8993(93)90025-i.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Sanders, D. B. "WS6-1 Neuromuscular transmission — overview." Clinical Neurophysiology 121 (October 2010): S79. http://dx.doi.org/10.1016/s1388-2457(10)60335-5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Jozefowicz, Ralph F. "Disorders of Neuromuscular Junction Transmission." Guthrie Journal 58, no. 1 (January 1989): 5–14. http://dx.doi.org/10.3138/guthrie.58.1.005.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Kurenkov, D. A., S. Yu Chizhevskaya, and E. M. Nikolaenko. "Objective monitoring of neuromuscular transmission in laparoscopic surgery." Kazan medical journal 94, no. 6 (December 15, 2013): 866–69. http://dx.doi.org/10.17816/kmj1808.

Повний текст джерела

Анотація:

Aim. To assess the importance of quantitative neuromuscular transmission monitoring in laparoscopic surgery. Methods. 30 patients [11 (37.7%) males, 19 (63.3%) females, mean age 52.3±7.18 years] who underwent laparoscopic surgery and general anesthesia associated with skeletal muscles relaxation, were examined. The degree of neuromuscular transmission recovery and time to trachea extubation performed by an anesthetist after the end of surgery (like laparoscopic cholecystectomy, appendectomy) and general anesthesia associated with skeletal muscles relaxation were assessed using quantitative monitoring of neuromuscular transmission and «blind» control. Results. In 21 patients no drugs were used to reverse the skeletal muscles relaxation. Trachea extubation in this group was performed 10.5 minutes after the end of surgery in average at the neuromuscular transmission Train of Four (TOF) level of 43-81% for 15 patients and at the TOF level over 90% in 6 patients. In 9 patients, sugammadex (2 mg/kg) was used for neuromuscular transmission reversal, the average level of neuromuscular blockade (TOF) in those patients was 41±6.5%. TOF average recovery time up to 90% was 1 minute 48 seconds. Trachea extubation was performed no later than 4 minutes after the sugammadex administration. Conclusion. The subjective assessment of neuromuscular transmission recovery, based on the assessment of clinical signs, is not able to completely exclude the residual muscle relaxation. Objective monitoring of neuromuscular transmission is required to determine the time of intubation, administration of maintenance doses of muscle relaxants, and for assessment of efficacy of reversal and possibility for trachea extubation.

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Ermilov, Leonid G., Juan N. Pulido, Fawn W. Atchison, Wen-Zhi Zhan, Mark H. Ereth, Gary C. Sieck, and Carlos B. Mantilla. "Impairment of diaphragm muscle force and neuromuscular transmission after normothermic cardiopulmonary bypass: effect of low-dose inhaled CO." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 298, no. 3 (March 2010): R784—R789. http://dx.doi.org/10.1152/ajpregu.00737.2009.

Повний текст джерела

Анотація:

Cardiopulmonary bypass (CPB) is associated with significant postoperative morbidity, but its effects on the neuromuscular system are unclear. Recent studies indicate that even relatively short periods of mechanical ventilation result in significant neuromuscular effects. Carbon monoxide (CO) has gained recent attention as therapy to reduce the deleterious effects of CPB. We hypothesized that 1) CPB results in impaired neuromuscular transmission and reduced diaphragm force generation; and 2) CO treatment during CPB will mitigate these effects. In adult male Sprague-Dawley rats, diaphragm muscle-specific force and neuromuscular transmission properties were measured 90 min after weaning from normothermic CPB (1 h). During CPB, either low-dose inhaled CO (250 ppm) or air was administered. The short period of mechanical ventilation used in the present study (∼3 h) did not adversely affect diaphragm muscle contractile properties or neuromuscular transmission. CPB elicited a significant decrease in isometric diaphragm muscle-specific force compared with time-matched, mechanically ventilated rats (∼25% decline in both twitch and tetanic force). Diaphragm muscle fatigability to 40-Hz repetitive stimulation did not change significantly. Neuromuscular transmission failure during repetitive activation was 60 ± 2% in CPB animals compared with 76 ± 4% in mechanically ventilated rats ( P < 0.05). CO treatment during CPB abrogated the neuromuscular effects of CPB, such that diaphragm isometric twitch force and neuromuscular transmission were no longer significantly different from mechanically ventilated rats. Thus, CPB has important detrimental effects on diaphragm muscle contractility and neuromuscular transmission that are largely mitigated by CO treatment. Further studies are needed to ascertain the underlying mechanisms of CPB-induced neuromuscular dysfunction and to establish the potential role of CO therapy.

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Fogarty, Matthew J., Maria A. Gonzalez Porras, Carlos B. Mantilla, and Gary C. Sieck. "Diaphragm neuromuscular transmission failure in aged rats." Journal of Neurophysiology 122, no. 1 (July 1, 2019): 93–104. http://dx.doi.org/10.1152/jn.00061.2019.

Повний текст джерела

Анотація:

In aging Fischer 344 rats, phrenic motor neuron loss, neuromuscular junction abnormalities, and diaphragm muscle (DIAm) sarcopenia are present by 24 mo of age, with larger fast-twitch fatigue-intermediate (type FInt) and fast-twitch fatigable (type FF) motor units particularly vulnerable. We hypothesize that in old rats, DIAm neuromuscular transmission deficits are specific to type FInt and/or FF units. In phrenic nerve/DIAm preparations from rats at 6 and 24 mo of age, the phrenic nerve was supramaximally stimulated at 10, 40, or 75 Hz. Every 15 s, the DIAm was directly stimulated, and the difference in forces evoked by nerve and muscle stimulation was used to estimate neuromuscular transmission failure. Neuromuscular transmission failure in the DIAm was observed at each stimulation frequency. In the initial stimulus trains, the forces evoked by phrenic nerve stimulation at 40 and 75 Hz were significantly less than those evoked by direct muscle stimulation, and this difference was markedly greater in 24-mo-old rats. During repetitive nerve stimulation, neuromuscular transmission failure at 40 and 75 Hz worsened to a greater extent in 24-mo-old rats compared with younger animals. Because type IIx and/or IIb DIAm fibers (type FInt and/or FF motor units) display greater susceptibility to neuromuscular transmission failure at higher frequencies of stimulation, these data suggest that the age-related loss of larger phrenic motor neurons impacts nerve conduction to muscle at higher frequencies and may contribute to DIAm sarcopenia in old rats. NEW & NOTEWORTHY Diaphragm muscle (DIAm) sarcopenia, phrenic motor neuron loss, and perturbations of neuromuscular junctions (NMJs) are well described in aged rodents and selectively affect FInt and FF motor units. Less attention has been paid to the motor unit-specific aspects of nerve-muscle conduction. In old rats, increased neuromuscular transmission failure occurred at stimulation frequencies where FInt and FF motor units exhibit conduction failures, along with decreased apposition of pre- and postsynaptic domains of DIAm NMJs of these units.

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Krivoi, Igor, and Alexey Petrov. "Cholesterol and the Safety Factor for Neuromuscular Transmission." International Journal of Molecular Sciences 20, no. 5 (February 28, 2019): 1046. http://dx.doi.org/10.3390/ijms20051046.

Повний текст джерела

Анотація:

A present review is devoted to the analysis of literature data and results of own research. Skeletal muscle neuromuscular junction is specialized to trigger the striated muscle fiber contraction in response to motor neuron activity. The safety factor at the neuromuscular junction strongly depends on a variety of pre- and postsynaptic factors. The review focuses on the crucial role of membrane cholesterol to maintain a high efficiency of neuromuscular transmission. Cholesterol metabolism in the neuromuscular junction, its role in the synaptic vesicle cycle and neurotransmitter release, endplate electrogenesis, as well as contribution of cholesterol to the synaptogenesis, synaptic integrity, and motor disorders are discussed.

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Grishin, S. N., A. E. Khairullin, A. Y. Teplov, and M. A. Mukhamedyarov. "Neuromuscular Transmission in a Barium Environment." Biophysics 67, no. 3 (June 2022): 457–60. http://dx.doi.org/10.1134/s000635092203006x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Stanec, A., and T. Baker. "Physiology and pharmacology of neuromuscular transmission." Current Opinion in Anaesthesiology 2, no. 4 (August 1989): 470–73. http://dx.doi.org/10.1097/00001503-198908000-00018.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Engbæk, J. "Measurement and monitoring of neuromuscular transmission." Current Opinion in Anaesthesiology 3, no. 4 (August 1990): 625–29. http://dx.doi.org/10.1097/00001503-199003040-00022.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Engbæk, J. "Measurement and monitoring of neuromuscular transmission." Current Opinion in Anaesthesiology 3, no. 4 (August 1990): 625–29. http://dx.doi.org/10.1097/00001503-199008000-00022.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Kopman, David, and Cynthia A. Lien. "Physiology and Pharmacology of Neuromuscular Transmission." ASA Refresher Courses in Anesthesiology 37, no. 1 (July 2009): 107–17. http://dx.doi.org/10.1097/asa.0b013e3181a6898d.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Ertas, Mustafa, and M. Baris Baslo. "Abnormal Neuromuscular Transmission in Cluster Headache." Headache: The Journal of Head and Face Pain 43, no. 6 (June 2003): 616–20. http://dx.doi.org/10.1046/j.1526-4610.2003.03103.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

LOAN, P. B., L. D. PAXTON, R. K. MIRAKHUR, F. M. CONNOLLY, and E. P. McCOY. "The TOF-Guard neuromuscular transmission monitor." Anaesthesia 50, no. 8 (August 1995): 699–702. http://dx.doi.org/10.1111/j.1365-2044.1995.tb06097.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Ross, R. "Neuromuscular transmission in the 17th century." Journal of Neurology, Neurosurgery & Psychiatry 51, no. 10 (October 1, 1988): 1268. http://dx.doi.org/10.1136/jnnp.51.10.1268.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Klose, M. K. "Stress-Induced Thermoprotection of Neuromuscular Transmission." Integrative and Comparative Biology 44, no. 1 (February 1, 2004): 14–20. http://dx.doi.org/10.1093/icb/44.1.14.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!